⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ONC News
BeOne Medicines Ltd. American Depositary Shares
BRUKINSA在初治慢性淋巴細胞白血病患者中取得里程碑式數據：六年無進展存活率達74%
businesswire.com
ONC
ASH 2025 confirma el potencial transformador de Sonrotoclax en el tratamiento de las neoplasias de células B
businesswire.com
ONC
Sonrotoclax在ASH 2025的數據確認其在B細胞惡性腫瘤中的基礎性潛力
businesswire.com
ONC
Dados de Sonrotoclax no ASH 2025 Confirmam Potencial Fundamental em Malignidades de Células B
businesswire.com
ONC
Sonrotoclax-Daten auf der ASH 2025 bestätigen grundlegendes Potenzial bei B-Zell-Malignomen
businesswire.com
ONC
Dati su sonrotoclax presentati all’ASH 2025 confermano il potenziale fondamentale nelle neoplasie a cellule B
businesswire.com
ONC
Gegevens over sonrotoclax op ASH 2025 bevestigen het fundamentele potentieel bij B-cel maligniteiten
businesswire.com
ONC
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies
businesswire.com
ONC
Amerikaanse FDA verleent prioritaire beoordeling aan Sonrotoclax voor de behandeling van recidiverend of refractair mantelcellymfoom
businesswire.com
ONC
A FDA dos EUA concede revisão prioritária ao sonrotoclax para tratar linfoma de células do manto reincidente ou refratário
businesswire.com
ONC